CCN2 and systemic sclerosis: Though those studies look at the fibroblast response, other published data show a more pronounced presence of CCN2 in the epidermal–dermal junction in those with early SSc, suggesting that epidermal production of CCN2 could contribute to the pro-fibrotic response in SSc [13].